EGFR mutation	Non Small Cell Lung Cancer	EGFR mutation	Non Small Cell Lung Cancer	zimberelimab + AB928 Sensitive: C2 – Inclusion Criteria zimberelimab + AB928 Sensitive : C2	zimberelimab + AB928 Sensitive: C2 – Inclusion Criteria zimberelimab + AB928 Sensitive : C2
PD-L1 overexpression	Non Small Cell Lung Cancer	PD-L1 overexpression	Non Small Cell Lung Cancer	zimberelimab + AB154 + AB928 Sensitive: C2 – Inclusion Criteria zimberelimab + AB154 + AB928 Sensitive : C2	zimberelimab + AB154 + AB928 Sensitive: C2 – Inclusion Criteria zimberelimab + AB154 + AB928 Sensitive : C2

Adenosine A2B receptor antagonist

Associations(2)